1387634-81-2

Basic information

• Product Name: 3-Chloro-2-isobutoxypyridine-5-boronic acid pinacol ester
• Synonyms: 3-Chloro-2-isobutoxypyridine-5-boronic acid pinacol ester;(5-CHLORO-6-ISOBUTOXYPYRIDIN-3-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 1387634-81-2
• Molecular Formula: C₁₅H₂₃BClNO₃
• Molecular Weight: 329.6273
• Mol File: 1387634-81-2.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-Chloro-2-isobutoxypyridine-5-boronic acid pinacol ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Chloro-2-isobutoxypyridine-5-boronic acid pinacol ester(1387634-81-2)
• EPA Substance Registry System: 3-Chloro-2-isobutoxypyridine-5-boronic acid pinacol ester(1387634-81-2)

Safety Data

• Hazardous Substances Data: 1387634-81-2(Hazardous Substances Data)

Upstream product

• 1289093-31-7 5-bromo-3-chloro-2-isobutoxypyridine 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 97966-00-2 5-bromo-2,3-dichloropyridine 
• 2402-77-9 2,3-dichloro-pyridine 
• 38185-56-7 5-bromo-3-chloro-2-fluoropyridine 
• 1288989-54-7 3-chloro-2-isobutoxy-pyridine 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1355066-42-0 5-chloro-6-isobutoxypyridin-3-ol 

Relevant articles and documents

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS. (I)

BIARYL ACYL-SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS

The present invention provides compounds of Formula (Ia), and pharmaceutically acceptable salts thereof. The compounds are useful as inhibitors of voltage-gated sodium channels, in particular Nav 1.7. (Ia); as described in the specification. The compounds are useful for the treatment of diseases treatable by inhibition of sodium channels such as pain disorders. Also provided are pharmaceutical compositions containing compounds of the present invention, as well as intermediates and processes useful for making the compounds.

TRICYCLIC SULFONAMIDE DERIVATIVES

The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.